Labcorp Q3 revenue rises to $3.56 billion; adjusted EPS $4.18 vs. $3.50 a year earlier
Labcorp reported third-quarter 2025 revenue of $3.56 billion, up from $3.28 billion, and diluted EPS of $3.12, up from $2.00. It raised its full-year adjusted EPS guidance midpoint by $0.05 and its free cash flow guidance midpoint by $25 million, but lowered its revenue growth guidance midpoint by 40 basis points, citing currency and acquisition timing.
Key points
- Q3 revenue was $3.56 billion versus $3.28 billion a year earlier; adjusted EPS was $4.18 versus $3.50.
- Full-year adjusted EPS guidance is now $16.15 to $16.50, with the midpoint raised by $0.05.
- Full-year revenue growth guidance is 7.4% to 8.0%, with the midpoint lowered 40 basis points due to currency and acquisition timing.
- Free cash flow guidance is $1.17 billion to $1.29 billion, with the midpoint raised by $25 million.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.